Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-02-21 @ 11:36 PM
Study NCT ID:
NCT02278458
Status:
UNKNOWN
Last Update Posted:
2015-05-22
First Post:
2014-10-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
Sponsor:
Betta Pharmaceuticals Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Cancer | View |
Keywords: